Novartis Ag (NVSEF) Net Cash Flow Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Cash Flow Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	-19.54%
Jun 30, 2025	-20.88%
Dec 31, 2024	-74.57%
Jun 30, 2024	-35.19%
Dec 31, 2023	75.20%
Jun 30, 2023	-16.66%
Dec 31, 2022	0.06%
Jun 30, 2022	-108.36%
Dec 31, 2021	6.85%
Mar 31, 2021	27.67%
Dec 31, 2020	20.30%
Dec 31, 2019	15.39%
Dec 31, 2018	-46.66%
Jun 30, 2018	2,500.45%
Dec 31, 2017	-19.86%
Dec 31, 2016	16.33%
Dec 31, 2015	10.25%
Dec 31, 2014	-28.33%